Uniphar, a diversified healthcare services organisation, agreed to acquire RRD International, a US-based pharmaceutical advisory group. Financial terms were not disclosed. "We are excited to announce the acquisition of RRD which adds significantly to our US Product Access capabilities. Becoming a truly global partner for our clients in this area is an important strategic objective for our group. The highly experienced RRD team brings deep US regulatory insights which will further accelerate our growth towards market leadership. The acquisition marks an important strategic milestone for the group and grows our US workforce to close to 170 colleagues," Ger Rabbette, Uniphar CEO.